Inspire Medical Systems Earnings Call: Key Takeaways
Inspire Medical reported a 7.9% year-over-year revenue decline due to $120 million in coding headwinds, while focusing on a 2027 return to growth.
- Call
- Nov 2, 2026, 5:00 PM ET
ALFA USA Filings
Every alert, straight from SEC EDGAR
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Inspire Medical Systems, Inc. filings on SEC EDGAR ↗
Filing type
Alerts
Time
3 alerts with these filters
Inspire Medical reported a 7.9% year-over-year revenue decline due to $120 million in coding headwinds, while focusing on a 2027 return to growth.
For the nine months ended September 30, 2026, Inspire Medical Systems reported a net loss of $35.4 million on revenue of $611.9 million, compared to a net profit of $9.3 million in the prior year period. The shift to a loss was driven by a decrease in revenue and a significant increase in selling, general, and administrative expenses.
Inspire Medical Systems reported Q3 2026 revenue of $206.7 million, a 7.9% decrease year-over-year primarily due to U.S. coding and reimbursement challenges. Despite the revenue decline, the company achieved a positive adjusted diluted EPS of $0.14 and noted that the AMA approved new Category I CPT codes for its Inspire V system effective 2028.
“We are pleased to have delivered sequential growth in the third quarter, with U.S. performance coming in ahead of our expectations. Results suggest that, despite some lingering headwinds, there is greater comfort among implanting physicians with the current coding dynamic.”
Tim Herbert, Chairman and CEO of Inspire Medical Systems
“Looking further ahead, we were also pleased with the AMA Editorial Panel’s September approval of a new CPT® code for single lead HGNS devices, including the Inspire V system. When this takes effect in January 2028, a dedicated code set will give physicians and hospitals enhanced clarity around coding and reimbursement and, in turn, further enable patient access to Inspire therapy.”
Tim Herbert, Chairman and CEO of Inspire Medical Systems